OC-0164: Nomogram validation for survival in patients with esophageal cancer receiving trimodality therapy
Lucas Goense(St. Antonius Ziekenhuis), Shuai Lin, Christopher L. Hallemeier(Mayo Clinic in Arizona), Jelle P. Ruurda(University Medical Center Utrecht), Kenneth W. Merrell(Mayo Clinic), Gert J. Meijer(University Medical Center Utrecht), Wayne L. Hofstetter(The University of Texas MD Anderson Cancer Center), Andrea Arnett(Mayo Clinic)
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Oesophageal cancer
|The Lancet|2024|265
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
|Practical Radiation Oncology|2021|261